Clinical Trials Directory

Trials / Unknown

UnknownNCT01399203

Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Guangdong Provincial People's Hospital · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

To investigate the predictive value of the contrast media volume to creatinine clearance (V/CrCl) ratio for the risk of contrast-induced nephropathy (CIN) (i.e., within 48-72 h) and to determine a relatively safe V/CrCl cut-off value to avoid CIN in patients following PCI

Detailed description

contrast media volume to creatinine clearance (V/CrCl) ratios were obtained from consecutive consenting patients after unselective PCI. Receiver-operator characteristic (ROC) curves were used to identify the optimal sensitivity for the observed range of V/CrCl. The predictive value of V/CrCl for the risk of CIN was assessed using multivariate logistic regression.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2011-10-01
Completion
2012-01-01
First posted
2011-07-21
Last updated
2011-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01399203. Inclusion in this directory is not an endorsement.